Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2021-02-20 Call Transcript
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Please find attached transcript of Investors and Analyst Conference Call organized on Thursday, 18th February, 2021 at 01.00 P.M. (IST) subsequent to declaration of unaudited standalone ....
Call Transcript Classification · 95% confidence The document is a transcript of an investors and analyst conference call discussing the quarterly financial results for Q3 FY 2020-2021. It includes detailed commentary from management on financial performance, business segments, growth metrics, and outlook. The text explicitly mentions it is a transcript of the earnings conference call held on February 18, 2021, subsequent to the declaration of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2020. This matches the definition of a Call Transcript (CT), which is a full text transcript of company conference calls such as earnings calls with Q&A. The document is lengthy (15,000 characters) and contains substantive discussion and Q&A, not just a brief announcement or summary, so it is not an Earnings Release (ER) or Report Publication Announcement (RPA). Therefore, the correct classification is CT with high confidence.
2021-02-20 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the issuance of duplicate share certificates and loss of share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about informing the exchanges about administrative actions related to share certificates, not about financial results, management changes, or other report types. The document is a regulatory announcement about share certificate status and does not contain financial data, management discussion, or voting results. It is not a report or a presentation but a formal notification to the exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-02-15 English
Morepen Laboratories Ltd has informed BSE regarding issuance of duplicate share certificates and loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the issuance of duplicate share certificates and loss of share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management and shareholder records. The content is about informing the exchanges about administrative actions related to share certificates, not about financial results, management changes, or other report types. The document is not a financial report, earnings release, or management discussion. It is a regulatory announcement related to share certificate issuance and loss. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-02-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation to stock exchanges about a scheduled conference call for investors and analysts regarding the Q3 FY 2020-2021 financial results. It includes details about the call timing, participants, dial-in numbers, and a brief company overview. There are no actual financial statements or detailed financial analysis included in the text. The document serves as a notification or announcement of the upcoming earnings call rather than the call transcript itself or the financial results report. Therefore, it fits best under the category of Call Transcript (CT) if it were the transcript, but since this is only an announcement of the call, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about the conference call. The document length (7460 characters) is moderate but the content is clearly an announcement, not the transcript or report itself.
2021-02-12 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that subsequent to the declaration of unaudited ....
Call Transcript Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the scheduling of a conference call for investors and analysts. It specifically mentions the call is to discuss the Q3 FY21 financial results, including a management discussion and Q&A session. The document does not contain actual financial statements or detailed financial analysis but serves as an announcement of the upcoming earnings call event. The length of the document (7292 characters) and the content indicate it is not the earnings release itself but an invitation/intimation for the conference call post-results. Therefore, the document fits the category of a Call Transcript announcement or invitation, but since it is only the intimation of the call and not the transcript itself, the closest fitting category is Call Transcript (CT) as it relates to the conference call event. Confidence is high given the clear references to the conference call for Q3 FY21 results and the detailed dial-in information provided.
2021-02-12 English
Please find enclosed the Investors Presentation (Q3'FY21) February 2021, based on the financial performance of the Company for the Quarter and Nine months ended 31st December, 2020.
Investor Presentation Classification · 95% confidence The document is titled 'Investors Presentation (Q3'FY21) February 2021' and is addressed to stock exchanges. It contains detailed financial performance data for the quarter and nine months ended December 31, 2020. The content includes segment-wise growth, manufacturing facilities, intellectual property, product details, and consolidated financial highlights with charts and ratios. The document is about 9,037 characters long, which is substantial and contains detailed financial and operational data, not just an announcement or a brief summary. The nature of the document is a presentation aimed at investors, focusing on financials, strategy, and market position for a specific quarter. Therefore, it fits the definition of an Investor Presentation (IP) rather than an Earnings Release (ER) or Interim Report (IR), as it is more comprehensive and formatted as a presentation.
2021-02-12 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.